{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:55:50Z","timestamp":1791608150669,"version":"4.3.4"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T00:00:00Z","timestamp":1687910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>Retinal vein occlusion (RVO) is a sight-threatening condition typically treated with intravitreal injection of vascular endothelial growth factor (VEGF) antagonists. Treatment response to anti-VEGF therapies is highly variable, with poor visual outcomes and treatment response in patients with significant retinal nonperfusion following RVO. Recently, caspase-9 has been identified as a potent regulator of edema, gliosis, and neuronal dysfunction during acute retinal hypoxia. The purpose of this study was to compare the therapeutic effect of caspase-9 inhibition against VEGF-neutralization in an established mouse model of RVO.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Adult male C57Bl\/6\u2009J mice were randomized to induction of RVO and treatment with either vehicle, intravitreal injection of anti-VEGF antibody, topical administration of a selective caspase-9 inhibitor (Pen1-XBir3), or a combination therapy. Animals were followed on days 1, 2, and 8 after RVO with fundus retinal imaging, and with optical coherence tomography (OCT) to capture retinal swelling, capillary nonperfusion (measured by disorganization of retinal inner layers, DRIL), hyperreflective foci (HRF), and retinal atrophy. Focal electroretinography (ERG) measurements were performed on day 7. Histology was performed on retinal sections from day 8.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Both VEGF neutralization and caspase-9 inhibition showed significant retinal protection from RVO compared to vehicle treatment arm. Retinal reperfusion of occluded veins was accelerated in eyes receiving caspase-9 inhibitor, but not significantly different from vehicle in the anti-VEGF group. Retinal edema was suppressed in all treatment groups, with approximately 2-fold greater edema reduction with caspase-9 inhibition compared to VEGF neutralization. HRF were reduced similarly across all treatment groups compared to vehicle. Retinal detachment was reduced only in eyes treated with caspase-9 inhibitor monotherapy. Caspase-9 inhibition reduced retinal atrophy and preserved ERG response; VEGF neutralization did not prevent neurodegeneration following RVO.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Caspase-9 inhibition confers stronger neuronal and vascular protection compared to VEGF neutralization in the mouse laser-induced model of RVO.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnins.2023.1209527","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T09:21:10Z","timestamp":1687944070000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Caspase-9 inhibition confers stronger neuronal and vascular protection compared to VEGF neutralization in a mouse model of retinal vein occlusion"],"prefix":"10.3389","volume":"17","author":[{"given":"Maria I.","family":"Avrutsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire W.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline M.","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott J.","family":"Snipas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy S.","family":"Salvesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol M.","family":"Troy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,28]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"8894","DOI":"10.1523\/JNEUROSCI.0698-11.2011","article-title":"Intranasal delivery of caspase-9 inhibitor reduces caspase-6-dependent axon\/neuron loss and improves neurological function after stroke","volume":"31","author":"Akpan","year":"2011","journal-title":"J. Neurosci."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15548627.2019.1695398","article-title":"CASP9 (caspase 9) is essential for autophagosome maturation through regulation of mitochondrial homeostasis","volume":"16","author":"An","year":"2019","journal-title":"Autophagy"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","article-title":"VEGF in signaling and disease: beyond discovery and development","volume":"176","author":"Apte","year":"2019","journal-title":"Cells"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1038\/s41467-020-16902-5","article-title":"Endothelial activation of caspase-9 promotes neurovascular injury in retinal vein occlusion","volume":"11","author":"Avrutsky","year":"2020","journal-title":"Nat. Commun."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"701301","DOI":"10.3389\/fphar.2021.701301","article-title":"Caspase-9: a multimodal therapeutic target with diverse cellular expression in human disease","volume":"12","author":"Avrutsky","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ophtha.2013.08.038","article-title":"Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN study","volume":"121","author":"Campochiaro","year":"2014","journal-title":"Ophthalmology"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1097\/IAE.0000000000001070","article-title":"Hyperreflective foci as an independent visual outcome predictor in macular edema due to retinal vascular diseases treated with intravitreal dexamethasone or ranibizumab","volume":"36","author":"Chatziralli","year":"2016","journal-title":"Retina"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3791\/63782","article-title":"In vivo vascular injury readouts in mouse retina to promote reproducibility","author":"Chen","year":"2022","journal-title":"J. Vis. Exp"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/s41419-022-05387-3","article-title":"Neurovascular injury associated non-apoptotic endothelial caspase-9 and astroglial caspase-9 mediate inflammation and contrast sensitivity decline","volume":"13","author":"Colon Ortiz","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3791\/62980","article-title":"Optimization of the retinal vein occlusion mouse model to limit variability","author":"Col\u00f3n Ortiz","year":"2021","journal-title":"J. Vis. Exp."},{"key":"ref300","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1042\/BJ20070288","article-title":"Caspase 3 attenuates XIAP (X-linked inhibitor of apoptosis protein)-mediated inhibition of caspase 9","volume":"405","author":"Denault","year":"2007","journal-title":"Biochem J"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1242\/jcs.163774","article-title":"Autocrine VEGF maintains endothelial survival through regulation of metabolism and autophagy","volume":"128","author":"Domigan","year":"2015","journal-title":"J. Cell Sci."},{"key":"ref400","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/978-1-60761-919-2_2","article-title":"Penetratin story: an overview","volume":"683","author":"Dupont","year":"2011","journal-title":"Methods Mol Biol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"43509","DOI":"10.1038\/srep43509","article-title":"A pharmacological approach in newly established retinal vein occlusion model","volume":"7","author":"Fuma","year":"2017","journal-title":"Sci. Rep."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1136\/bjophthalmol-2016-308813","article-title":"Optical coherence tomographic predictor of retinal non-perfused areas in eyes with macular oedema associated with retinal vein occlusion","volume":"101","author":"Hasegawa","year":"2017","journal-title":"Br. J. Ophthalmol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1097\/IAE.0000000000000843","article-title":"Retinal vein occlusions, from basics to the latest treatment","volume":"36","author":"Ho","year":"2016","journal-title":"Retina"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"6175","DOI":"10.1167\/iovs.17-22788","article-title":"Animal models of retinal vein occlusion","volume":"58","author":"Khayat","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.survophthal.2018.04.005","article-title":"Ischemic retinal vein occlusion: characterizing the more severe spectrum of retinal vein occlusion","volume":"63","author":"Khayat","year":"2018","journal-title":"Surv. Ophthalmol."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"605","DOI":"10.18240\/ijo.2017.04.17","article-title":"Evaluation of hyperreflective foci as a prognostic factor of visual outcome in retinal vein occlusion","volume":"10","author":"Mo","year":"2017","journal-title":"Int. J. Ophthalmol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"4701","DOI":"10.1167\/iovs.18-23994","article-title":"Pathophysiological role of VEGF on retinal edema and nonperfused areas in mouse eyes with retinal vein occlusion","volume":"59","author":"Nishinaka","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"9614","DOI":"10.1038\/s41598-020-66708-0","article-title":"Prediction of post-treatment retinal sensitivity by baseline retinal perfusion density measurements in eyes with branch retinal vein occlusion","volume":"10","author":"Rachima","year":"2020","journal-title":"Sci. Rep."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1172\/JCI17712","article-title":"Proinflammatory functions of vascular endothelial growth factor in alloimmunity","volume":"112","author":"Reinders","year":"2003","journal-title":"J. Clin. Invest."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3390\/cells9030687","article-title":"VEGF triggers transient induction of autophagy in endothelial cells via AMPK\u03b11","volume":"9","author":"Spengler","year":"2020","journal-title":"Cells"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1136\/bjophthalmol-2016-308668","article-title":"Five-year visual acuity outcomes and injection patterns in patients with pro-re-nata treatments for AMD, DME, RVO and myopic CNV","volume":"101","author":"Wecker","year":"2017","journal-title":"Br. J. Ophthalmol."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1209527\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T09:21:12Z","timestamp":1687944072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1209527\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,28]]},"references-count":24,"alternative-id":["10.3389\/fnins.2023.1209527"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2023.1209527","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,28]]},"article-number":"1209527"}}